ClinicalTrials.gg
Not yet recruitingNCT07595406CERVESPUpdated May 19, 2026

Cervical Medial Branch Block Versus Ipsilateral Cervical Erector Spinae Plane Block

An interventional study of Ultrasound-guided cervical medial branch block and Ultrasound-guided cervical erector spinae plane block in Cervical Facetogenic Pain, Chronic Neck Pain and Cervical Facet Joint Syndrome, sponsored by Ankara City Hospital Bilkent. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-19.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 297 studies in Neck Pain with a site in Turkey — 68 open to participants now, 76 under way, none of them phase 3. Neck Pain · Turkey.

Planned enrollment
3rd of 216
130 · median 45
Started
2026
with 41 others
No phase
215 of 297
46 open now
Primary completion
2026-09
later than 57 of 75 live
Registered
264th of 297
by date

Among the 297 studies in Neck Pain with a site in Turkey, this one is the 3rd largest by planned enrollment of the 216 interventional ones that give a count, is one of 42 that started in 2026, is one of 215 with no phase, reaches primary completion later than 57 of the 75 other live ones, and was the 264th registered.

Neck Pain

1,367 studies on the registry are indexed under Neck Pain; 301 are open to participants now.

Browse Neck Pain studies →

Open to participants now

68 of the 297 studies in Neck Pain with a site in Turkey are open now. Recruiting first, the newest first:

63 more — sign in →

All 68 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 158 Neck Pain studies recruiting now, 25 (16%) set no upper age limit and 120 (76%) stop at 75 or younger; 8 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 297 studies in Neck Pain with a site in Turkey, or all of them as a file.
02

Study summary

This prospective randomized controlled study aims to compare the analgesic effectiveness of ultrasound-guided cervical medial branch block and ipsilateral cervical erector spinae plane block in patients with cervical facetogenic pain.

Patients with chronic cervical facet-mediated pain will be randomized into two intervention groups. Pain intensity, functional status, meaningful pain response rates, analgesic consumption, and patient satisfaction will be evaluated during follow-up.

The primary objective is to determine whether cervical erector spinae plane block provides comparable short-term pain relief to cervical medial branch block.

Read the detailed description

Cervical facet joints are an important source of chronic axial neck pain. Diagnostic cervical medial branch block is commonly used to identify facet-mediated pain and may also provide short-term analgesic benefit. However, this procedure requires precise targeting of the cervical medial branches and may be technically demanding in some patients.

The cervical erector spinae plane block is an ultrasound-guided interfascial plane block that may provide analgesia through cranio-caudal spread of local anesthetic along the paraspinal fascial plane. Although it has been increasingly used for perioperative and chronic pain indications, its role in cervical facetogenic pain has not been clearly established.

This study will compare the short-term analgesic effectiveness of ultrasound-guided cervical medial branch block and ipsilateral cervical erector spinae plane block in patients with clinically suspected cervical facetogenic pain. Eligible patients will be randomized to receive one of the two ultrasound-guided interventions. Pain intensity, functional disability, meaningful pain response, analgesic use, patient satisfaction, and procedure-related adverse events will be assessed during follow-up.

The study is designed to determine whether cervical erector spinae plane block can provide clinically meaningful pain relief comparable to cervical medial branch block in this patient population.

03

Conditions studied

  • Cervical Facetogenic Pain
  • Chronic Neck Pain
  • Cervical Facet Joint Syndrome
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 80 years
  • Chronic neck pain lasting at least 3 months
  • Clinical findings suggestive of cervical facetogenic pain
  • Numeric Rating Scale pain score ≥4
  • Ability to provide

Exclusion criteria

Exclusion Criteria:

  • Cervical radiculopathy or myelopathy
  • Major neurological deficit
  • Infection at the injection site
  • Coagulopathy or anticoagulant therapy contraindicating intervention
  • Allergy to local anesthetics
  • Pregnancy
  • Previous cervical interventional pain procedure within the last 3 months
  • Severe psychiatric disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Cervical Medial Branch Block

    Ultrasound-guided cervical medial branch block will be performed at the clinically suspected symptomatic cervical facet levels.

    Other: Ultrasound-guided cervical medial branch block

  • Experimental
    Cervical Erector Spinae Plane Block

    Ultrasound-guided ipsilateral cervical erector spinae plane block will be performed at the symptomatic cervical level. I

    Other: Ultrasound-guided cervical erector spinae plane block

Interventions

  • OtherUltrasound-guided cervical medial branch block

    Ultrasound-guided cervical medial branch block performed at clinically suspected symptomatic cervical facet levels using local anesthetic for diagnostic and analgesic purposes.

  • OtherUltrasound-guided cervical erector spinae plane block

    Ultrasound-guided ipsilateral cervical erector spinae plane block performed at the symptomatic cervical level using local anesthetic for analgesic purposes.

06

What researchers measure

Primary outcomes

  1. Meaningful Pain Response

    Proportion of patients achieving at least 50% reduction in Numeric Rating Scale (NRS) pain score during the early post-procedural period.

    Time frame: Time Frame: 1 hour after the procedure

Secondary outcomes

  1. NRS24

    Change in pain intensity measured using the 11-point Numeric Rating Scale (0=no pain, 10=worst imaginable pain).

    Time frame: at 24 Hours

  2. NRS1

    Change in pain intensity measured using the 11-point Numeric Rating Scale.( 0=no pain, 10=worst imaginable pain)

    Time frame: 1 week after the procedure

  3. NDI

    Functional disability associated with neck pain assessed using the Neck Disability Index.0 = no disability 50 = complete disability Higher scores indicate greater neck-related functional disability (worse outcome).

    Time frame: Baseline and 1 week after the procedure

  4. GPE

    Patient-reported global improvement evaluated using a 7-point Global Perceived Effect scale. The GPE scale ranges from -5 to +5, where: -5 = vastly worse 0 = no change +5 = completely recovered

    Time frame: 1 week after the procedure

  5. Analgesic Consumption

    Need for rescue analgesic medication after the procedure.

    Time frame: 24 hours and 1 week after the procedure

  6. Patient Satisfaction

    Patient satisfaction regarding the procedure.

    Time frame: 1 week after the procedure

  7. Complications

    Procedure-related adverse events and complications.

    Time frame: Perioperative/Periprocedural

07

Study locations

1 site
08

References and documents

Publications

  • Elsharkawy H, Ince I, Hamadnalla H, Drake RL, Tsui BCH. Cervical erector spinae plane block: a cadaver study. Reg Anesth Pain Med. 2020 Jul;45(7):552-556. doi: 10.1136/rapm-2019-101154. Epub 2020 Apr 21. PubMed 32321860 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Sep 2026, 3 months later.

Of 768 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 3 months is below that.

Counting every sponsor, half of 777 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2026
First posted
May 19, 2026
StartEst.
May 31, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Dec 31, 2026
Last update
May 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07595406
Responsible party
Ülkü Sabuncu (Assoc Prof, Ankara City Hospital Bilkent) — Principal investigator
First posted
May 19, 2026
Start date
May 31, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 19, 2026

Study contacts

Ülkü Sabuncu, Assoc prof
Contact
sabuncuulku@gmail.com
905337085212

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion